Bright Minds Biosciences Inc. (DRUG) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 49.21 |
| Open | 49.66 |
| Day High | 51.04 |
| Day Low | 48.83 |
| 52-Week High | 123.75 |
| 52-Week Low | 48.53 |
| Volume | 154,687 |
| Average Volume | 161,103 |
| Market Cap | 496.11M |
| PE | -24.37 |
| EPS | -2.08 |
| Moving Average 50 Days | 69.45 |
| Moving Average 200 Days | 76.71 |
| Change | 1.48 |
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
GlobeNewswire Inc.
Sep 19, 2024 2:00 PM GMT
Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on September 25th.The event will feature Epilepsy KOLs to d